programas cribado cancer


Nota Bibliográfica

Esta Nota es una recopilación de publicaciones (artículos, informes, libros) sobre cribado de cáncer resultado de una revisión no sistemática de la literatura.

Podéis dirigir vuestros comentarios o sugerencias sobre la Nota a:

Josep A Espinás. Pla Director d'Oncología de Catalunya.
Correo electrónico: Esta dirección electrónica esta protegida contra spam bots. Necesita activar JavaScript para visualizarla

Nota bibliográfica cribado de c colorrectal 2012-10

Castells A. Cribado del cáncer colorrectal. Gastroenterologia y Hepatologia 2012 Sep;35, Supplement 1(0):68-73.  DOI: doi: 10.1016/S0210-5705(12)70036-5
Resumen El cáncer colorrectal es una de las neoplasias que más puede beneficiarse de medidas preventivas, en especial del cribado. Para ello se dispone de diversas estrategias coste-efectivas: la detección de sangre oculta en heces mediante pruebas químicas (guayaco) o inmunoló¦gicas, y la realización de pruebas endoscópicas como la sigmoidoscopia flexible o la colonoscopia. En el presente artí¡culo se revisan las comunicaciones más relevantes presentadas en el congreso anual de la American Gastroenterological Association, celebrado en San Diego en mayo de 2012, en relación con el cribado del cáncer colorrectal, haciendo especial hincapié en su efectividad, por lo que respecta a la reducción de la incidencia y/o la mortalidad asociada a esta neoplasia.
Whyte S, Chilcott J, Halloran S. Reappraisal of the options for colorectal cancer screening in England. Colorectal Disease 2012;14(9):e547-e561DOI: 10.1111/j.1463-1318.2012.03014.x
Conclusions: Strategies which combine different screening modalities may provide greater clinical and economic benefits. The collection of comprehensive screening data using a uniform format will enable comparative analysis across screening programmes in different countries, will improve our understanding of the disease and will allow identification of optimal screening modalities


Nota bibliográfica cribado de c colorrectal 2012-09

Anonymous. Making smart screening decisions. Part 1: colon cancer screening. Learn which colorectal cancer tests you need, and how often you need them. Harv Womens Health Watch 2012 Sep;20(1):6-7.  PM:23035328
Jover R, Herráiz M, Alarcón O, Brullet E, Bujanda L, Bustamante M, et al. Clinical practice Guidelines: quality of colonoscopy in colorectal cancer screening. Endoscopy 2012;44(04):444-51.  DOI: 10.1055/s-0032-1306690
Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012 Sep 1;143(3):844-57.
Stoop EM, de Wijkerslooth TR, Bossuyt PM, Stoker J, Fockens P, Kuipers EJ, et al. Face-to-face vs telephone pre-colonoscopy consultation in colorectal cancer screening; a randomised trial. Br J Cancer 2012 Sep 25;107(7):1051-8.


Nota bilbiográfica cribado c colorectal 2012-08

Brenner H, Chang-Claude J, Rickert A, Seiler CM, Hoffmeister M. Risk of Colorectal Cancer After Detection and Removal of Adenomas at Colonoscopy: Population-Based Case-Control Study. J Clin Oncol 2012 Aug 20;30(24):2969-76.  DOI: 10.1200/JCO.2011.41.3377
Conclusion Extension of surveillance intervals to 5 years should be considered, even after detection and removal of high-risk polyps
Morris EJA, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012 Aug 21;107(5):757-64.
Morris S, Baio G, Kendall E, von Wagner C, Wardle J, Atkin W, et al. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme. Br J Cancer 2012 Aug 21;107(5):765-71.


Nota bibliográfica cribado c colorrectal 2012-07

Gill MD, Bramble MG, Rees CJ, Lee TJW, Bradburn DM, Mills SJ. Comparison of screen-detected and interval colorectal cancers in the Bowel Cancer Screening Programme. Br J Cancer 2012 Jul 24;107(3):417-21.
Libby G, Brewster DH, McClements PL, Carey FA, Black RJ, Birrell J, et al. The impact of population-based faecal occult blood test screening on colorectal cancer mortality: a matched cohort study. Br J Cancer 2012 Jul 10;107(2):255-9.
Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012 Jul;61(7):1036-40.  DOI: gutjnl-2011-300774 [pii];10.1136/gutjnl-2011-300774 [doi]  PM:22052062
CONCLUSIONS: Although the reduction in CRC mortality was sustained, further follow-up of the screened population has not shown a significant reduction in the CRC incidence. Moreover, despite the removal of many large adenomas there was no reduction in the incidence of invasive cancer which was independent of sex and site of the tumour

Terhaar sive Droste J, van Turenhout S, Oort F, van der Hulst R, Steeman V, Coblijn U, et al. Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study. BMC Gastroenterology 2012;12(1):94.  DOI: 10.1186/1471-230X-12-94
CONCLUSIONS: In once-only FIT sampling before surveillance colonoscopy, 70% of advanced neoplasia were missed. A simulation approach indicates that multiple screening rounds may be more promising in detecting advanced neoplasia and could potentially alleviate endoscopic burden

Young GP, Fraser CG, Halloran SP, Cole S. Guaiac based faecal occult blood testing for colorectal cancer screening: an obsolete strategy? editorial. Gut 2012 Jul;61(7):959-60.  PMC3355341  DOI: gutjnl-2011-301810 [pii];10.1136/gutjnl-2011-301810 [doi]  PM:22345655


Nota bibliográfica cribado c colorrectal 2012-06

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, et al. Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network. Int J Cancer 2012 Jun 15;130(12):2961-73.  DOI: 10.1002/ijc.26310 [doi]
The International Colorectal Cancer Screening Network was established in 2003 to promote best practice in the delivery of organized colorectal cancer screening programs. To facilitate evaluation of such programs, we defined a set of universally applicable colorectal cancer screening measures and indicators. To test the feasibility of data collection, we requested data on these variables and basic program characteristics from 26 organized full programs and 9 pilot programs in 24 countries. The size of the target population for each program varied considerably from a few thousand to 36 million. The majority of programs used fecal occult blood tests for primary screening, with more using guaiac than immunochemical tests. There was wide variation in the ability of screening programs to report the requested measures and in the values reported. In general, pilot programs were more likely to provide screening measure values than were full programs. As expected, detection rates for polyps and neoplasia were substantially higher in programs screening with endoscopy than in those using fecal occult blood tests. It is hoped that the screening measures and indicators, once revised in the light of this survey, will be adopted and used by existing programs and those in the early planning stages, allowing international comparison with the goal of improved colorectal cancer screening quality

Foley KL, Song EY, Klepin H, Geiger A, Tooze J. Screening colonoscopy among colorectal cancer survivors insured by Medicaid. Am J Clin Oncol 2012 Jun;35(3):205-11.  DOI: 10.1097/COC.0b013e318209d21e [doi]
CONCLUSIONS: Less than half of Medicaid-insured colorectal cancer survivors received a colonoscopy in 3 to 18 months after colorectal resection. Improvements in screening in this high-risk population should be the target of future interventions to reduce the probability of recurrence

Garcia M, Mila N, Binefa G, Borras JM, Espinas JA, Moreno V. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010. J Med Screen 2012 May 31.  DOI: jms.2012.012013 [pii];10.1258/jms.2012.012013 [doi]
CONCLUSION: The proportion of false-positive results and the associated risks should be estimated to provide an eligible population with more reliable information on the adverse effects of screening

Inadomi JM. Why you should care about screening flexible sigmoidoscopy. N Engl J Med 2012 Jun 21;366(25):2421-2.  DOI: 10.1056/NEJMe1204099 [doi]
Kim ER, Sinn DH, Kim JY, Chang DK, Rhee PL, Kim JJ, et al. Factors associated with adherence to the recommended postpolypectomy surveillance interval. Surg Endosc 2012 Jun;26(6):1690-5.  DOI: 10.1007/s00464-011-2094-2 [doi]
CONCLUSIONS: Nonadherence to the recommended guidelines was associated with the endoscopist's concern for missed polyps. Improving colonoscopic skills and bowel preparation may decrease nonadherence to the recommended postpolypectomy surveillance interval

Moss S. Colonoscopy as a primary screening method? editorial. J Med Screen 2012 Jun 1;19(2):55-6.  DOI: 10.1258/jms.2012.012058
Pendlimari R, Holubar SD, Hassinger JP, Cima RR. Assessment of Colon Cancer Literacy in screening colonoscopy patients: a validation study. J Surg Res 2012 Jun 15;175(2):221-6.  DOI: S0022-4804(11)00416-1 [pii];10.1016/j.jss.2011.04.036 [doi]
CONCLUSIONS: The ACCL is a valid, sensitive measure of health literacy. Furthermore, given its focus on clinically relevant content, this instrument may facilitate discussion of diagnosis, treatment, and prognosis with colon cancer patients. ACCL is a novel, valid health literacy instrument that may aid gastroenterologists, colorectal surgeons, and medical oncologists in optimizing patient education

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012 Jun 21;366(25):2345-57.  DOI: 10.1056/NEJMoa1114635 [doi]
CONCLUSIONS: Screening with flexible sigmoidoscopy was associated with a significant decrease in colorectal-cancer incidence (in both the distal and proximal colon) and mortality (distal colon only).


Página 6 de 19

web desarrollada y mantenida por :